Your browser doesn't support javascript.
loading
Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline.
Duggan, Michael R; Peng, Zhongsheng; Sipilä, Pyry N; Lindbohm, Joni V; Chen, Jingsha; Lu, Yifei; Davatzikos, Christos; Erus, Guray; Hohman, Timothy J; Andrews, Shea J; Candia, Julián; Tanaka, Toshiko; Joynes, Cassandra M; Alvarado, Chelsea X; Nalls, Mike A; Cordon, Jenifer; Daya, Gulzar N; An, Yang; Lewis, Alexandria; Moghekar, Abhay; Palta, Priya; Coresh, Josef; Ferrucci, Luigi; Kivimäki, Mika; Walker, Keenan A.
Afiliação
  • Duggan MR; Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Peng Z; Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Sipilä PN; Clinicum, Department of Public Health, University of Helsinki, Helsinki, Finland.
  • Lindbohm JV; Finnish Institute of Occupational Health, Helsinki, Finland.
  • Chen J; Clinicum, Department of Public Health, University of Helsinki, Helsinki, Finland.
  • Lu Y; Broad Institute of the MIT and Harvard University, The Klarman Cell Observatory, Cambridge, MA, USA.
  • Davatzikos C; Brain Sciences, University College London, London, UK.
  • Erus G; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Hohman TJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Andrews SJ; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
  • Candia J; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
  • Tanaka T; Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Joynes CM; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Alvarado CX; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA.
  • Nalls MA; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Cordon J; Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Daya GN; Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • An Y; Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
  • Lewis A; Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
  • Moghekar A; DataTecnica LLC, Washington, DC, USA.
  • Palta P; Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
  • Coresh J; DataTecnica LLC, Washington, DC, USA.
  • Ferrucci L; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
  • Kivimäki M; Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Walker KA; Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
Nat Aging ; 4(9): 1263-1278, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39143319
ABSTRACT
Infections have been associated with the incidence of Alzheimer disease and related dementias, but the mechanisms responsible for these associations remain unclear. Using a multicohort approach, we found that influenza, viral, respiratory, and skin and subcutaneous infections were associated with increased long-term dementia risk. These infections were also associated with region-specific brain volume loss, most commonly in the temporal lobe. We identified 260 out of 942 immunologically relevant proteins in plasma that were differentially expressed in individuals with an infection history. Of the infection-related proteins, 35 predicted volumetric changes in brain regions vulnerable to infection-specific atrophy. Several of these proteins, including PIK3CG, PACSIN2, and PRKCB, were related to cognitive decline and plasma biomarkers of dementia (Aß42/40, GFAP, NfL, pTau-181). Genetic variants that influenced expression of immunologically relevant infection-related proteins, including ITGB6 and TLR5, predicted brain volume loss. Our findings support the role of infections in dementia risk and identify molecular mediators by which infections may contribute to neurodegeneration.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia / Encéfalo / Proteômica / Disfunção Cognitiva Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia / Encéfalo / Proteômica / Disfunção Cognitiva Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article